330 related articles for article (PubMed ID: 12122979)
1. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
[TBL] [Abstract][Full Text] [Related]
3. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Hiller E
Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
6. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
7. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
8. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
10. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
[TBL] [Abstract][Full Text] [Related]
11. Intermittent pneumatic compression in stable claudicants: effect on hemostasis and endothelial function.
Sutkowska E; Wozniewski M; Gamian A; Gosk-Bierska I; Alexewicz P; Sutkowski K; Wysokinski WE
Int Angiol; 2009 Oct; 28(5):373-9. PubMed ID: 19935591
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation.
Skrabal CA; Choi YH; Kaminski A; Steiner M; Kundt G; Steinhoff G; Liebold A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):291-6. PubMed ID: 16872952
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction.
Tombul T; Atbas C; Anlar O
J Clin Neurosci; 2005 May; 12(4):429-34. PubMed ID: 15925775
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; Abdel-Lateef AE; Aly R
J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke.
Dai DF; Thajeb P; Tu CF; Chiang FT; Chen CH; Yang RB; Chen JJ
J Am Coll Cardiol; 2008 Jun; 51(22):2173-80. PubMed ID: 18510966
[TBL] [Abstract][Full Text] [Related]
16. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
[TBL] [Abstract][Full Text] [Related]
17. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
[TBL] [Abstract][Full Text] [Related]
19. Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function.
Xue J; Dong Q; Han X; You H; Gu Y; Lin S
Ther Apher Dial; 2007 Jun; 11(3):171-6. PubMed ID: 17497997
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
